Basal Insulin Peglispro Demonstrates Preferential Hepatic Versus Peripheral Action Relative to Insulin Glargine in Healthy Subjects.
- Published in:
- Diabetes Care, 2014, v. 37, n. 9, p. 2609, doi. 10.2337/dc14-0210
- By:
- Publication type:
- Article
Works by Prince, Melvin J
Results: 16
1
2
Lower Glucose Variability and Hypoglycemia Measured by Continuous Glucose Monitoring With Novel Long-Acting Insulin LY2605541 Versus Insulin Glargine.
- Published in:
- Diabetes Care, 2014, v. 37, n. 3, p. 659, doi. 10.2337/dc12-2621
- By:
- Publication type:
- Article
3
Response to Comment on: Bergenstal et al. A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes. Diabetes Care 2012;35:2140-2147.
- Published in:
- 2013
- By:
- Publication type:
- Letter
4
Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin-Treated Patients With Type2 Diabetes. Diabetes Care 2012;35: 2140-2147.
- Published in:
- Diabetes Care, 2013, v. 36, n. 7, p. e107, doi. 10.2337/dc13-0295
- By:
- Publication type:
- Article
5
Better glycemic control and weight loss with the novel long-acting basal insulin LY2605541 compared with insulin glargine in type 1 diabetes: a randomized, crossover study.
- Published in:
- 2013
- By:
- Publication type:
- journal article
6
Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes.
- Published in:
- Diabetes Care, 2013, v. 36, n. 3, p. 522, doi. 10.2337/dc12-0067
- By:
- Publication type:
- Article
7
Autophosphorylation of cultured skin fibroblast insulin receptors from patients with severe insulin resistance and acanthosis nigricans.
- Published in:
- 1989
- By:
- Publication type:
- journal article
8
Functional characteristics of decreased insulin receptors on fibroblasts obtained from a subject with severe insulin resistance and acanthosis nigricans.
- Published in:
- 1986
- By:
- Publication type:
- journal article
9
Insulin binding, internalization, and insulin receptor regulation in fibroblasts from type II, non-insulin-dependent diabetic subjects.
- Published in:
- 1981
- By:
- Publication type:
- journal article
10
What the UKPDS really says about cardiovascular disease and glycemic control.
- Published in:
- 1999
- By:
- Publication type:
- Journal Article
11
What the UKPDS really says about cardiovascular disease and glycemic control.
- Published in:
- Clinical Diabetes, 1999, v. 17, n. 3, p. 109
- By:
- Publication type:
- Article
12
A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes.
- Published in:
- 2012
- By:
- Publication type:
- journal article
13
A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin--Treated PatientsWith Type 2 Diabetes.
- Published in:
- Diabetes Care, 2012, v. 35, n. 11, p. 2140, doi. 10.2337/dc12-0060
- By:
- Publication type:
- Article
14
The Hypotriglyceridemic Effect of Fish Oil in Adult-Onset Diabetes without Adverse Glucose Control <sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1993, v. 683, n. 1, p. 337, doi. 10.1111/j.1749-6632.1993.tb35725.x
- By:
- Publication type:
- Article
15
Reduced nocturnal hypoglycaemia with basal insulin peglispro compared with insulin glargine: pooled analyses of five randomized controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 11, p. 1093, doi. 10.1111/dom.12757
- By:
- Publication type:
- Article
16
BLOOD GLUCOSE CONTROL IN DIABETICS: III.
- Published in:
- Seminars in Dialysis, 1993, v. 6, n. 6, p. 397, doi. 10.1111/j.1525-139X.1993.tb00189.x
- By:
- Publication type:
- Article